AstraZeneca Stock Forecast, Price & News

AstraZeneca's stock was trading at $44.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AZN stock has increased by 23.6% and is now trading at $55.11.
View which stocks have been most impacted by COVID-19.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for AstraZeneca.

AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for AstraZeneca.

AstraZeneca plc (NYSE:AZN) announced its quarterly earnings results on Thursday, July, 30th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.04. The business earned $6.28 billion during the quarter, compared to the consensus estimate of $6.27 billion. AstraZeneca had a return on equity of 37.72% and a net margin of 8.36%. The business's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 EPS.
View AstraZeneca's earnings history.

AstraZeneca declared a semi-annual dividend on Friday, July 31st. Investors of record on Friday, August 14th will be given a dividend of $0.45 per share on Monday, September 14th. This represents a yield of 2.5%. The ex-dividend date is Thursday, August 13th.
View AstraZeneca's dividend history.

Shares of AstraZeneca split on Monday, July 27th 2015. The 2-1 split was announced on Friday, June 26th 2015. The newly issued shares were payable to shareholders after the closing bell on Friday, July 24th 2015. An investor that had 100 shares of AstraZeneca stock prior to the split would have 200 shares after the split.

11 brokers have issued twelve-month price objectives for AstraZeneca's stock. Their forecasts range from $60.00 to $65.00. On average, they expect AstraZeneca's stock price to reach $61.67 in the next year. This suggests a possible upside of 11.9% from the stock's current price.
View analysts' price targets for AstraZeneca.

News coverage about AZN stock has been trending somewhat negative on Wednesday, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AstraZeneca earned a news sentiment score of -1.6 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about AstraZeneca.

AstraZeneca saw a decline in short interest in August. As of August 31st, there was short interest totaling 4,130,000 shares, a decline of 37.2% from the August 15th total of 6,580,000 shares. Based on an average trading volume of 6,690,000 shares, the short-interest ratio is currently 0.6 days.
View AstraZeneca's Short Interest.

Some companies that are related to AstraZeneca include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Sanofi (SNY), Commonwealth Bank of Australia (CSLLY), GlaxoSmithKline (GSK), Zoetis (ZTS) and Celgene (CELG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include Pfizer (PFE), Gilead Sciences (GILD), Johnson & Johnson (JNJ), NVIDIA (NVDA), Moderna (MRNA), Tesla (TSLA), AbbVie (ABBV), AT&T (T), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

AstraZeneca trades on the New York Stock Exchange (NYSE) under the ticker symbol "AZN."

Shares of AZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AZN stock can currently be purchased for approximately $55.11.

AstraZeneca has a market capitalization of $144.63 billion and generates $24.38 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $1.75 on an earnings per share basis. AstraZeneca employs 70,600 workers across the globe.

The official website for AstraZeneca is www.astrazeneca.com.

AstraZeneca's mailing address is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. The company can be reached via phone at 44-20-3749-5000 or via email at [email protected]